MOLECULAR QUALITY CONTROL MARKET ANALYSIS

Molecular Quality Control Market by Product Type (Independent Control, Instrument Specific Control (DNA Sequencing and NGS, PCR, and Others)), by Analyte (Single Analyte, and Multi Analyte), by Application (Oncology, Genetic Testing, Infectious Diseases, and Others), by End Users (Clinical Laboratories, Hospitals and Clinics, Research and Academic Institutes, and Others), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI2674
Formats :
Excel and PDF
Industry : Medical Devices

Market Challenges And Opportunities

Molecular Quality Control Market Restraints

Inaccurate genetic tests are expected to hinder growth of the molecular quality control market. For instance, in August 2017, Invitae Corporation identified a quality control issue with a hereditary cancer test, which provided false, negative results. This hereditary cancer test is carried out on those patient who have a rare genetic variant in the MSH2 gene which is associated with the Lynch syndrome.